<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05120206</url>
  </required_header>
  <id_info>
    <org_study_id>94605</org_study_id>
    <nct_id>NCT05120206</nct_id>
  </id_info>
  <brief_title>The Impact of Cigarette Smoking on Periodontal Therapy</brief_title>
  <official_title>Outcomes of Periodontal Therapy in Smokers and Non-smokers With Chronic Periodontitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Bergen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Bergen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Periodontitis patients, 40 cigarette smokers and 40 non-smokers (defined by cotinine measures&#xD;
      in serum), were recruited to this double arm prospective cohort study. Data were collected 3&#xD;
      months following non-surgical and surgical periodontal treatment, and following 12 months&#xD;
      with supportive periodontal therapy. Data collected were clinical attachment level, probing&#xD;
      depth, bleeding on probing,oral bacteria, serum, blood (PAXgeneBlood), and gingival&#xD;
      crevicular fluid.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The overall aim of this work was to study clinical outcomes of active and supportive&#xD;
      periodontal therapy in smokers and non-smokers with chronic periodontitis at patient, tooth,&#xD;
      and site level. Moreover, to compare the periopathogenic microflora and inflammatory markers&#xD;
      in gingival crevicular fluid and in blood in smokers and non-smokers following therapy.&#xD;
&#xD;
      Eighty patients, 40 smokers and 40 non-smokers, with moderate to severe chronic periodontitis&#xD;
      were included in this prospective cohort study and treated non-surgically and surgically, and&#xD;
      then followed-up in a supportive periodontal therapy program for 12 months. Smoking status&#xD;
      was validated measuring serum cotinine levels at pre-treatment and 12 months following&#xD;
      supportive periodontal therapy.&#xD;
&#xD;
      Clinical measurements included full mouth recordings of clinical attachment level, probing&#xD;
      depth, bleeding on probing, and plaque index at pre-treatment and following active and&#xD;
      supportive periodontal therapy. At the same timepoints, subgingival plaque samples of 20&#xD;
      subgingival periopathogenic bacterial species were analysed using checkerboard DNA-DNA&#xD;
      hybridization. Blood samples (PAXgeneBlood), serum, gingval crevicular fluid were also&#xD;
      collected at the three timepoints.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 1, 2012</start_date>
  <completion_date type="Actual">March 1, 2015</completion_date>
  <primary_completion_date type="Actual">March 1, 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Prospective cohort study</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>PD ≥5 mm with BoP</measure>
    <time_frame>24 months</time_frame>
    <description>Corrected for clustering within patients, teeth, and sites over time, was the unit of the analysis and PD ≥5 mm with BoP was the outcome (dependent variable) dichotomized as present (1) or absent (0).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Teeth present</measure>
    <time_frame>24 months</time_frame>
    <description>Number of teeth</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical periodontal attachmentloss</measure>
    <time_frame>24 months</time_frame>
    <description>Clinical attachment loss in mm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Periodontal pocket depth</measure>
    <time_frame>24 months</time_frame>
    <description>Probing depth in mm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bleeding at site level</measure>
    <time_frame>24 months</time_frame>
    <description>Bleeding on probing (yes or no)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bleeding at patient level</measure>
    <time_frame>24 months</time_frame>
    <description>Bleeding index in percentage (%)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plaque at patient level</measure>
    <time_frame>24 months</time_frame>
    <description>Plaque index in percentage (%)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Amount of periopathogenic bacteria</measure>
    <time_frame>24 months</time_frame>
    <description>Subgingival plaque samples of 20 subgingival periopathogenic bacterial species were analysed using checkerboard DNA-DNA hybridization.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inflammatory gingival crevicular fluid markers (proteins)</measure>
    <time_frame>24 months</time_frame>
    <description>Concentrations of gingival crevicular fluid biomarkers measured in pg/mLwere analysed using multiplex and singleplex micro-bed immunoassays.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum proteins</measure>
    <time_frame>24 months</time_frame>
    <description>Concentration of inflammatory serum markers measured in pg/ɥL determined using multiplex kit Bio-Plex Human ProTM Assay.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gene expression in blood</measure>
    <time_frame>24 months</time_frame>
    <description>Inflammatory gene (RNA) expression levels is estimated by counting the reads that map to genes or exones using the the RPKM (Reads per Kilobases per Million reads) methods.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Periodontitis</condition>
  <condition>Cigarette Smoking</condition>
  <arm_group>
    <arm_group_label>Cigarette smokers with periodontitis</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Periodontal therapy in cigarette smokers</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-smokers with periodontitis</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Periodontal therapy in non-smokers</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Non-surgical periodontal therapy: motivation and instruction in oral hygiene, debridement using handinstrumentation (Hu-Firedy,Chicago, IL, USA;and American Eagle Instruments,Missoula, MT,USA).</intervention_name>
    <description>Non-surgical and surgical periodontal therapy in cigarette smokers and non-smokers</description>
    <arm_group_label>Cigarette smokers with periodontitis</arm_group_label>
    <arm_group_label>Non-smokers with periodontitis</arm_group_label>
    <other_name>Periodontal surgery: periodontal flap and gingivectomy with postoperative rinse with 0.2% chlorhexidine gluconate (Corsodyl, GlaxoSmithKline, London, UK).</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  healthy subjects&#xD;
&#xD;
          -  age 35-75 years&#xD;
&#xD;
          -  diagnosed with chronic periodontitis&#xD;
&#xD;
          -  at least four non-adjacent teeth with proximal sites with a PD ≥6 mm and clinical&#xD;
             attachment loss ≥5 mm with BoP and no radiographic signs of apical pathology.&#xD;
&#xD;
          -  either smokers (&gt;10 cigarettes per day for at least 5 years) or non-smokers (never&#xD;
             smoked or not within the last 5 years).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  subjects who presented with any current medical condition or used medications known to&#xD;
             affect periodontal healing&#xD;
&#xD;
          -  incorrectly reported smoking status&#xD;
&#xD;
          -  use of antibiotics within 6 months of the study&#xD;
&#xD;
          -  received subgingival scaling within 6 months of the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dagmar F. Bunæs, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Clinical Dentistry - periodontics, University of Bergen, Norway</affiliation>
  </overall_official>
  <results_reference>
    <citation>Bunaes DF, Lie SA, Enersen M, Aastrøm AN, Mustafa K, Leknes KN. Site-specific treatment outcome in smokers following non-surgical and surgical periodontal therapy. J Clin Periodontol. 2015 Oct;42(10):933-42. doi: 10.1111/jcpe.12462. Epub 2015 Oct 28.</citation>
    <PMID>26407817</PMID>
  </results_reference>
  <results_reference>
    <citation>Bunaes DF, Mustafa M, Mohamed HG, Lie SA, Leknes KN. The effect of smoking on inflammatory and bone remodeling markers in gingival crevicular fluid and subgingival microbiota following periodontal therapy. J Periodontal Res. 2017 Aug;52(4):713-724. doi: 10.1111/jre.12438. Epub 2017 Mar 17.</citation>
    <PMID>28306142</PMID>
  </results_reference>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>October 5, 2021</study_first_submitted>
  <study_first_submitted_qc>November 2, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 15, 2021</study_first_posted>
  <last_update_submitted>November 2, 2021</last_update_submitted>
  <last_update_submitted_qc>November 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chlorhexidine</mesh_term>
    <mesh_term>Chlorhexidine gluconate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

